ARTICLES
The 22q11.2 Deletion in Children: High Rate of Autistic Disorders and Early Onset of Psychotic Symptoms

https://doi.org/10.1097/01.chi.0000228131.56956.c1Get rights and content

ABSTRACT

Objective

To examine psychopathology and influence of intelligence level on psychiatric symptoms in children with the 22q11.2 deletion syndrome (22q11DS).

Method

Sixty patients, ages 9 through 18 years, were evaluated. Assessments followed standard protocols, including structured and semistructured interviews of parents, videotaped psychiatric interview, and intelligence assessment of the child. Intelligence level, psychiatric symptoms, and classification provided the main outcome.

Results

High rates of autism spectrum disorders (30 of 60, 50.0%) and psychotic symptoms (16 of 60, 26.7%) were found in this sample. In 7 of 60 (11.7%), the psychotic symptoms interfered with behavior and caused considerable distress. In these cases, the diagnosis of a psychotic disorder was applied. The average age of the children with psychotic symptoms at time of assessment was 14.2 years. Although it is likely that the high rate of psychopathology in this sample is to some extent associated with the lower level of cognitive function, a major effect of the degree of cognitive impairment on psychiatric morbidity was not found.

Conclusion

Autism spectrum disorders and subthreshold autistic symptomatology are common in children with 22q11DS. Furthermore, a high rate of psychosis and psychotic symptoms is found in this childhood sample, suggesting an early onset of psychosis in 22q11DS patients. Autistic and psychotic disorders should be considered to be main elements of the behavioral phenotype of 22q11DS children. J. Am. Acad. Child Adolesc. Psychiatry, 2006;45(9):1104–1113.

Section snippets

Subjects

All children (N = 60, inclusion criterion age 9–20 years) were presented by their parents through publicity on the Web site and a newsletter of the parents' network of 22q11DS children in The Netherlands. An estimated 40% to 50% of Dutch parents with school-age children with 22q11DS is affiliated with this association. Furthermore, the information on the Web site is accessible to everyone. To further minimize the effect of selection bias, the information provided to the parents stated that

DSM-IV Classification and Frequency of Symptoms

Table 2 summarizes the diagnostic findings of the present study. The ASD group consisted of 30 patients (50.0%); 27 patients were diagnosed pervasive developmental disorder not otherwise specified, and three patients were diagnosed as having autism. With respect to the symptoms as measured by the ADI-R, 20 patients (33.3%) had ADI-R scores beyond the cutoff values in the three core domains (social interaction, communication, stereotyped behaviors). Of the remaining patients, 11.7% were found to

Psychopathology

The primary finding of the present study is a high rate of ASDs (50.0%) and psychosis (11.7%), including psychosis not otherwise specified and schizophrenia. Taken together, 66.7% of participants had one or more psychiatric disorders according to DSM-IV criteria.

When focusing on the presence of hallucinations and/or delusions, as a finer measure of psychopathology, a total of 16 (26.7%) of the participants reported at least one of these psychotic symptoms. The young age at assessment of these

REFERENCES (56)

  • TM Achenbach

    Manual for the Child Behavior Checklist/4–18 and 1991 YSR and TRF profiles

    (1991)
  • PD Arnold et al.

    Velo-cardio-facial syndrome: implications of microdeletion 22q11 for schizophrenia and mood disorders

    Am J Med Genet

    (2001)
  • KD Baker et al.

    Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group

    Br J Psychiatry

    (2005)
  • AS Bassett et al.

    The schizophrenia phenotype in 22q11 deletion syndrome

    Am J Psychiatry

    (2003)
  • AS Bassett et al.

    Clinical features of 78 adults with 22q11 deletion syndrome

    Am J Med Genet A

    (2005)
  • PF Bolton et al.

    Autism, affective and other psychiatric disorders: patterns of familial aggregation

    Psychol Med

    (1998)
  • LD Botto et al.

    A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population

    Pediatrics

    (2003)
  • JK Buitelaar et al.

    Diagnostic rules for children with PDD-NOS and multiple complex developmental disorder

    J Child Psychol Psychiatry

    (1998)
  • M Cannon et al.

    Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences

    Am J Psychiatry

    (1997)
  • C Carlson et al.

    Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders

    Am J Hum Genet

    (1997)
  • P Castelloe et al.

    Subclassification of children with autism and pervasive developmental disorder: a questionnaire based on Wing’s subgrouping scheme

    J Autism Dev Disord

    (1993)
  • CK Conners

    Conners Rating Scales-Revised

    (1997)
  • EJ Costello et al.

    Prevalence and development of psychiatric disorders in childhood and adolescence

    Arch Gen Psychiatry

    (2003)
  • A de Bildt et al.

    Interrelationship between Autism Diagnostic Observation Schedule-Generic (ADOS-G), Autism Diagnostic Interview-Revised (ADI-R), and the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) classification in children and adolescents with mental retardation

    J Autism Dev Disord

    (2004)
  • DJ Done et al.

    Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11

    BMJ

    (1994)
  • L Edelmann et al.

    A common molecular basis for rearrangement disorders on chromosome 22q11

    Hum Mol Genet

    (1999)
  • SE Fine et al.

    Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome

    J Autism Dev Disord

    (2005)
  • E Fombonne

    Epidemiological trends in rates of autism

    Mol Psychiatry

    (2002)
  • Cited by (0)

    This study was sponsored in part by a research grant from the Hersenstichting Nederland (Dutch Brain Foundation). The authors thank W.G. Staal, M.D., Ph.D., F.E. Scheepers, M.D., Ph.D., and R.S. Simons, M.Sc., for their assistance in the child psychiatry clinic and E.P. Martens, M.Sc., for statistical advice.

    Deceased.

    View full text